250 related articles for article (PubMed ID: 30386178)
1. Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design.
Shankar S; Sreekumar A; Prasad D; Das AV; Pillai MR
Cancer Cell Int; 2018; 18():169. PubMed ID: 30386178
[TBL] [Abstract][Full Text] [Related]
2. The comparison of ZFNs, TALENs, and SpCas9 by GUIDE-seq in HPV-targeted gene therapy.
Cui Z; Liu H; Zhang H; Huang Z; Tian R; Li L; Fan W; Chen Y; Chen L; Zhang S; Das BC; Severinov K; Hitzeroth II; Debata PR; Jin Z; Liu J; Huang Z; Xie W; Xie H; Lang B; Ma J; Weng H; Tian X; Hu Z
Mol Ther Nucleic Acids; 2021 Dec; 26():1466-1478. PubMed ID: 34938601
[TBL] [Abstract][Full Text] [Related]
3. TALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cells.
Shankar S; Prasad D; Sanawar R; Das AV; Pillai MR
Sci Rep; 2017 Jul; 7(1):5500. PubMed ID: 28710417
[TBL] [Abstract][Full Text] [Related]
4. Genome editing with CompoZr custom zinc finger nucleases (ZFNs).
Hansen K; Coussens MJ; Sago J; Subramanian S; Gjoka M; Briner D
J Vis Exp; 2012 Jun; (64):e3304. PubMed ID: 22732945
[TBL] [Abstract][Full Text] [Related]
5. TALENs-an indispensable tool in the era of CRISPR: a mini review.
Bhardwaj A; Nain V
J Genet Eng Biotechnol; 2021 Aug; 19(1):125. PubMed ID: 34420096
[TBL] [Abstract][Full Text] [Related]
6. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
[TBL] [Abstract][Full Text] [Related]
7. Origins of Programmable Nucleases for Genome Engineering.
Chandrasegaran S; Carroll D
J Mol Biol; 2016 Feb; 428(5 Pt B):963-89. PubMed ID: 26506267
[TBL] [Abstract][Full Text] [Related]
8. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
Guha TK; Edgell DR
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
[TBL] [Abstract][Full Text] [Related]
9. Engineering of Zinc Finger Nucleases Through Structural Modeling Improves Genome Editing Efficiency in Cells.
Katayama S; Watanabe M; Kato Y; Nomura W; Yamamoto T
Adv Sci (Weinh); 2024 Jun; 11(23):e2310255. PubMed ID: 38600709
[TBL] [Abstract][Full Text] [Related]
10. Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapy.
Aghamiri S; Talaei S; Roshanzamiri S; Zandsalimi F; Fazeli E; Aliyu M; Kheiry Avarvand O; Ebrahimi Z; Keshavarz-Fathi M; Ghanbarian H
Expert Opin Drug Deliv; 2020 Jun; 17(6):753-766. PubMed ID: 32281426
[TBL] [Abstract][Full Text] [Related]
11. Basics of genome editing technology and its application in livestock species.
Petersen B
Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
[TBL] [Abstract][Full Text] [Related]
12. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity.
Mussolino C; Morbitzer R; Lütge F; Dannemann N; Lahaye T; Cathomen T
Nucleic Acids Res; 2011 Nov; 39(21):9283-93. PubMed ID: 21813459
[TBL] [Abstract][Full Text] [Related]
13. Efficient methods for targeted mutagenesis in zebrafish using zinc-finger nucleases: data from targeting of nine genes using CompoZr or CoDA ZFNs.
Sood R; Carrington B; Bishop K; Jones M; Rissone A; Candotti F; Chandrasekharappa SC; Liu P
PLoS One; 2013; 8(2):e57239. PubMed ID: 23451191
[TBL] [Abstract][Full Text] [Related]
14. Inclusion of homologous DNA in nuclease-mediated gene targeting facilitates a higher incidence of bi-allelically modified cells.
Beaton BP; Kwon DN; Choi YJ; Kim JH; Samuel MS; Benne JA; Wells KD; Lee K; Kim JH; Prather RS
Xenotransplantation; 2015; 22(5):379-90. PubMed ID: 26381494
[TBL] [Abstract][Full Text] [Related]
15. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
[TBL] [Abstract][Full Text] [Related]
16. The Antitumor Efficiency of Zinc Finger Nuclease Combined with Cisplatin and Trichostatin A in Cervical Cancer Cells.
Ren C; Gao C; Li X; Xiong J; Shen H; Wang L; Zhu D; Wu P; Ding W; Wang H
Anticancer Agents Med Chem; 2020; 20(17):2125-2135. PubMed ID: 32753022
[TBL] [Abstract][Full Text] [Related]
17. Improvements of nuclease and nickase gene modification techniques for the treatment of genetic diseases.
Lu Y; Happi Mbakam C; Song B; Bendavid E; Tremblay JP
Front Genome Ed; 2022; 4():892769. PubMed ID: 35958050
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus.
Gutierrez-Guerrero A; Sanchez-Hernandez S; Galvani G; Pinedo-Gomez J; Martin-Guerra R; Sanchez-Gilabert A; Aguilar-González A; Cobo M; Gregory P; Holmes M; Benabdellah K; Martin F
Hum Gene Ther; 2018 Mar; 29(3):366-380. PubMed ID: 28922955
[TBL] [Abstract][Full Text] [Related]
19. Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases.
Cai Y; Bak RO; Mikkelsen JG
Elife; 2014 Apr; 3():e01911. PubMed ID: 24843011
[TBL] [Abstract][Full Text] [Related]
20. Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing.
Yan W; Smith C; Cheng L
Sci Rep; 2013; 3():2376. PubMed ID: 23921522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
